PEAR THERAPEUTICS INC (PEAR)

US7047231052 - Common Stock

0.0292  -0.02 (-38.91%)

After market: 0.0287 0 (-1.71%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
12.69M4.21M0.00
Cost Of Goods
7.39M5.23MN/A
Gross Profit
5.30M-1.02MN/A
Operating Expenses
122.47M104.66M2.18K
Research and Development
44.40M37.04MN/A
Selling, General, and Administrative Expenses
78.07M67.62MN/A
Operating Income
-117.17M-105.69M-2.18K
Interest Income/Expense
-3.89M-4.14MN/A
Other Income/Expense
51.75M44.69MN/A
Non Recurring Items
-6.18M0.00N/A
Income Before Taxes
-75.49M-65.14M-2.18K
Net Income
-75.49M-65.14M-2.18K
EBITDA
-113.20M-103.43MN/A
 
Per Share Data
EPS Diluted Total Ops
-0.54-0.57-0.00
 
Statistics
Gross Profit Margin
41.75%-24.36%N/A
Profit Margin
-594.70%-1548.05%N/A
Operating Profit Margin
-923.02%-2511.53%N/A

All data in USD

Charts